Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Burroni

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Blood Cells, Molecules & Diseases|November 9, 2021
Malignant histiocytosis with a Langerhans cell subtype: A report on the diagnostic and therapeutic challengeAmel Kime, Claire Bréal, Anne-Ségolène Cottereau, et al.
Annals of Hematology|July 1, 2020
Safety and efficacy of temsirolimus in combination with three different immuno-chemotherapy regimens in relapse and refractory mantle cell lymphoma, final results of the T<sup>3</sup> phase IB trial of the LYSABenoît Tessoulin, Kamal Bouabdallah, Barbara Burroni, et al.
Haematologica|April 25, 2020
Integrated analyses of translatome and proteome identify the rules of translation selectivity in RPS14-deficient cellsIsmael Boussaid, Salomé Le Goff, Célia Floquet, et al.
Leukemia|January 11, 2020
Bone marrow niche-derived extracellular matrix-degrading enzymes influence the progression of B-cell acute lymphoblastic leukemiaDivij Verma, Costanza Zanetti, Parimala Sonika Godavarthy, et al.
International Journal of Surgical Pathology|May 9, 2023
EBV-Positive Inflammatory Follicular Dendritic Cell Sarcoma of the Spleen: Report of an Aggressive Form With Molecular CharacterizationAlistair Baber, Paul Legendre, Patricia Palmic, et al.
British Journal of Haematology|September 11, 2018
CD13 expression in B cell malignancies is a hallmark of plasmacytic differentiationAnna Raimbault, Sigrid Machherndl-Spandl, Raphaël Itzykson, et al.
Annals of Hematology|October 6, 2021
Different number of circulating CD34 + cells in essential thrombocythemia, prefibrotic/early primary myelofibrosis, and overt primary myelofibrosisDamien Luque Paz, Laurane Cottin, Eric Lippert, et al.
Plos One|September 20, 2014
Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancerMarco Alifano, Audrey Mansuet-Lupo, Filippo Lococo, et al.
Haematologica|August 3, 2019
Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET ProjectClément Bailly, Thomas Carlier, Alina Berriolo-Riedinger, et al.
The Lancet. Haematology|October 10, 2024
Maternal and obstetric outcomes in women with pregnancy-associated haematological malignancies: an observational nationwide cohort studyPierre Pinson, Ismael Boussaid, Justine Decroocq, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Blood Cells, Molecules & Diseases|November 9, 2021
Malignant histiocytosis with a Langerhans cell subtype: A report on the diagnostic and therapeutic challengeAmel Kime, Claire Bréal, Anne-Ségolène Cottereau, et al.
Annals of Hematology|July 1, 2020
Safety and efficacy of temsirolimus in combination with three different immuno-chemotherapy regimens in relapse and refractory mantle cell lymphoma, final results of the T<sup>3</sup> phase IB trial of the LYSABenoît Tessoulin, Kamal Bouabdallah, Barbara Burroni, et al.
Haematologica|April 25, 2020
Integrated analyses of translatome and proteome identify the rules of translation selectivity in RPS14-deficient cellsIsmael Boussaid, Salomé Le Goff, Célia Floquet, et al.
Leukemia|January 11, 2020
Bone marrow niche-derived extracellular matrix-degrading enzymes influence the progression of B-cell acute lymphoblastic leukemiaDivij Verma, Costanza Zanetti, Parimala Sonika Godavarthy, et al.
International Journal of Surgical Pathology|May 9, 2023
EBV-Positive Inflammatory Follicular Dendritic Cell Sarcoma of the Spleen: Report of an Aggressive Form With Molecular CharacterizationAlistair Baber, Paul Legendre, Patricia Palmic, et al.
British Journal of Haematology|September 11, 2018
CD13 expression in B cell malignancies is a hallmark of plasmacytic differentiationAnna Raimbault, Sigrid Machherndl-Spandl, Raphaël Itzykson, et al.
Annals of Hematology|October 6, 2021
Different number of circulating CD34 + cells in essential thrombocythemia, prefibrotic/early primary myelofibrosis, and overt primary myelofibrosisDamien Luque Paz, Laurane Cottin, Eric Lippert, et al.
Plos One|September 20, 2014
Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancerMarco Alifano, Audrey Mansuet-Lupo, Filippo Lococo, et al.
Haematologica|August 3, 2019
Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET ProjectClément Bailly, Thomas Carlier, Alina Berriolo-Riedinger, et al.
The Lancet. Haematology|October 10, 2024
Maternal and obstetric outcomes in women with pregnancy-associated haematological malignancies: an observational nationwide cohort studyPierre Pinson, Ismael Boussaid, Justine Decroocq, et al.
Pageof 6